BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jul 29, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

MST-188: QT/QTc study data

A 4-way crossover, double-blind, placebo-controlled QT study in 64 healthy volunteers showed that MST-188 was generally well tolerated at both therapeutic and supratherapeutic doses and had no effect on QTcF interval. Patients received therapeutic and supratherapeutic...

Read the full 159 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >